BriaCell Therapeutics Corp. (BCTXL) — Cash & Equivalents
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $10.49M | +1117.3% |
| 2024 | $862.1K | -95.9% |
| 2023 | $21.25M | -48.2% |
| 2022 | $41.04M | -28.3% |
| 2021 | $57.27M | — |
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $10.49M | +1117.3% |
| 2024 | $862.1K | -95.9% |
| 2023 | $21.25M | -48.2% |
| 2022 | $41.04M | -28.3% |
| 2021 | $57.27M | — |